Serum IL-17F does not predict poor response to IM IFN -1a in relapsing-remitting MS

Title
Serum IL-17F does not predict poor response to IM IFN -1a in relapsing-remitting MS
Authors
Keywords
-
Journal
NEUROLOGY
Volume 79, Issue 6, Pages 531-537
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-05-10
DOI
10.1212/wnl.0b013e318259e123

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started